As previously mentioned, although the “Partnership” between Gal-9 and TIM-3 is being explored in cancer research, with studies on Gal-9 in malignant hematological diseases and solid tumors primarily focus on the Gal-9/TIM-3 pathway. This evidence concerns the gene HAVCR2 and cancer.